Aurobindo Pharma experienced a slight dip in Q4FY25 net profit, despite a revenue increase. However, the company saw significant growth in net profit and revenue for the entire fiscal year 2024-25 ...

Aurobindo Pharma posted a marginal decrease in its net profit at ₹903 crore in the fourth quarter ended March 31, 2025, compared with ₹907 crore in the corresponding quarter of the previous ...

Aurobindo Ackroyd Ghosh, the polymath Indian philosopher, freedom fighter, and revolutionary yogi, was trained in England in the Classics (St. Paul’s School and King’s College, Cambridge); it ...

Generic drugmaker Aurobindo Pharma reported consolidated net profit for the March quarter declined marginally to ₹903 crore compared with ₹907 crore a year earlier. The lower net profit came ...

Aurobindo Pharma on Monday reported a marginal dip in its consolidated profit after tax to Rs 903 crore for the fourth quarter ended March 2025. The Hyderabad-based drug maker posted a profit ...

Aurobindo Pharma’s (ARBP) Q4FY25 EBITDA of Rs17.9bn (up 6% YoY) was in line with our estimate. FY26 guidance of high single digit revenue growth ex gRevlimid with flat margins was below our ...

The domestic equity benchmark indices, Sensex and Nifty 50, are expected to open higher on May 26, following positive cues from global markets. Asian markets traded higher, while the US stock ...

Big stake sales, new business deals, and quarterly numbers kept the action going in the stock market. Some companies reported with huge profit jumps, while others made headlines with plans to ...

Aurobindo Pharma, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1196.4. The stock has experienced fluctuations today, with a ...

Aurobindo Pharma Limited (APL), one of the worlds top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy ...

WASHINGTON, DC (IANS) – Drug makers Dr Reddy’s Laboratories, Sun Pharma and Aurobindo Pharma are recalling their products in the US due to manufacturing issues. According to the latest ...